CUSIP: 78397T202 | NYSE | Healthcare · Biotechnology | Micro Cap | 136 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13D/ARA Capital Management, L.P. | 9,609,852 | 9.9% | +2,298,627 | Aug 6, 2026 | 37d ahead of 13F (4,401,500 sh) · +5,208,352 |
| 13G/AVivo Opportunity Fund Holdings, L.P. with Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P. |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 2,198,500 | $7.0M | 1.1% | Deep Value | Very Low | Paris, India | 2026-11-05 | |
| 307,717 | $975.5K | 0.0% | Index | Very Low | Atlanta, GA | 2026-10-23 | |
| 119,688 | $379.4K | 0.0% | Yield | Low | Denver, CO | 2026-11-03 | |
| 104,849 | $332.4K | 0.0% | Core | Low | Las Vegas, NV | 2026-10-27 | |
| 49,811 | $157.9K | 0.0% | Core | Low | Austin, TX | 2026-11-02 | |
| 25,705 | $81.5K | 0.0% | Growth | Low | Tampa, FL | 2026-10-16 | |
| 18,986 | $60 | 0.0% | Core | Very Low | Sioux Falls, SD | 2026-10-13 | |
| 6,383 | $20.2K | 0.0% | Core | Very High | Chicago, IL | 2026-11-04 | |
| 5,925 | $18.8K | 0.0% | ETF | Very Low | Southfield, MI | 2026-11-04 | |
| 2,688 | $8.5K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 1,070 | $3.4K | 0.0% | GARP | Medium | Charlotte, NC | 2026-10-22 | |
| 96 | $304 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 | |
| 21 | $67 | 0.0% | Index | Low | San Francisco, CA | 2026-10-08 | |
| 14 | $45 | 0.0% | ETF | Very Low | Sylvania, OH | 2026-10-26 | |
| 3 | $10 | 0.0% | ETF | Medium | Encinitas, CA | 2026-10-21 | |
| 2 | $6 | 0.0% | Core | Medium | Birmingham, AL | 2026-11-04 |
| 22,637,108 |
| 10.0% |
| New 5%+ stake |
| Jun 30, 2026 |
| No 13F filer matched |
| 13G/ABalyasny Asset Management L.P. | 7,225,439 | 9.4% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| 13G/APerceptive Life Sciences Master Fund, Ltd. | 6,627,501 | 7.3% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| 13GAdage Capital Management, L.P. | 6,405,553 | 8.4% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| 13G/ACommodore Capital LP | 8,948,170 | 9.9% | New 5%+ stake | — |